Labeling Changes

QuestionsCategory: QuestionsLabeling Changes
Jacqueline asked 3 weeks ago

Recently, the FDA approved labeling changes for extended release (ER) and long acting opioid medications. I would hope that any Dr. or Pharmacist is already aware of this fact when it’s being prescribed for a patient??? It should be obvious especially if ER is included in the drug name. I really fail to see how this reduces any “risks” as is being claimed. Seems like total nonsense to me. Doesn’t the Fraud and Drug Administration (yes, sarcasm) have more important things to do ?

Jeffrey FudinJeffrey Fudin Staff replied 3 weeks ago

Jacqueline, I don’t disagree necessarily, but I feel that the FDA is trying to make a blanket statement to warn of risks – yes, we all know the risks with or without the warning!